Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot.
EpiVax Demonstrates Antigen-Specific Tolerance Induction in Allergy with Tregitopes, Results Published in Frontiers in Immunology
PROVIDENCE, RI, April 27, 2021 /PRNewswire/ --...
EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)
PROVIDENCE, RI, February 17, 2021 /PRNewswire/...
EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
PROVIDENCE, R.I., Dec. 31, 2020 /PRNewswire/ --...
EpiVax Advances “PANDA” Peptide Therapeutic Immunogenicity Screening Program
PROVIDENCE, R.I., Dec. 29,...
EpiVax Reports Record Year for Immunogenicity Screening Toolkit (ISPRI)
PROVIDENCE, RI, December 15, 2020 /PRNewswire/...
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
PROVIDENCE, RI, October 22, 2020 /PRNewswire/ --...
EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
PROVIDENCE, RI, August 24, 2020 /PRNewswire/ --...
TIDES US Virtual 2020
With the 2020 TIDES USA Virtual conference right...
Six months in, are we any closer to a vaccine?
Are we "Checking the Box" or Making Vaccines...
Press Release: EpiVax Announces Licensing of Immunogenicity Screening Toolkit, ISPRI, to AbCellera
PROVIDENCE, RI, June 8, 2020 /PRNewswire/ --...
Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine
Bilthoven, The Netherlands, Providence, R.I.,...
Press Release: Pacific GeneTech Partners With EpiVax on a Novel Vaccine Approach for ASF
HONG KONG, May 1, 2020 (Newswire.com) - Pacific...